טוען...
Strategies for Predicting Response to Checkpoint Inhibitors
PURPOSE OF REVIEW: Despite the clinical successes of immune checkpoint blockade across multiple tumor types, many patients do not respond to these therapies or become resistant after an initial response. This underscores the need to improve our understanding of the molecular determinants of response...
שמור ב:
| הוצא לאור ב: | Curr Hematol Malig Rep |
|---|---|
| Main Authors: | , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2018
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6719799/ https://ncbi.nlm.nih.gov/pubmed/30159703 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11899-018-0471-9 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|